Management of hypertension in an Australian community pharmacy setting – patients' beliefs and perspectives

International Journal of Pharmacy Practice

Volumn 25, Issue 4, 2017, Pages 263-273

  Bajorek, Beata V ^a   LeMay, Kate S ^b   Magin, Parker J ^c   Roberts, Christopher ^d   Krass, Ines ^b   Armour, Carol L ^b,e  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d HORNSBY KU RING GAI HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

community pharmacy; hypertension; medication adherence; patient perspectives; pharmacy service

Indexed keywords

ARTICLE; AUSTRALIA; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERTENSION; INTERVIEW; MEDICATION COMPLIANCE; PATIENT ATTITUDE; PATIENT PARTICIPATION; PERSONAL EXPERIENCE; PHARMACIST; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONAL-PATIENT RELATIONSHIP; QUALITATIVE RESEARCH; TRUST; ATTITUDE TO HEALTH; HEALTH PERSONNEL ATTITUDE; INTERPERSONAL COMMUNICATION; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT SATISFACTION; PERCEPTION; PROFESSIONAL STANDARD; PSYCHOLOGY;

ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; COMMUNICATION; COMMUNITY PHARMACY SERVICES; DRUG PRESCRIPTIONS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MEDICATION ADHERENCE; PATIENT CARE TEAM; PATIENT SATISFACTION; PERCEPTION; PHARMACISTS; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; QUALITATIVE RESEARCH;

EID: 84993947011     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/ijpp.12301     Document Type: Article

References (38)

1. Ho P et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med 2008; 168: 271–276.
2. Janus E et al. Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle risk factor study 2004-2006. Intern Med J 2008; 38: 879–886.
3. Glynn L et al. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010; 3: Cd005182 Epub 2010/03/20. doi: 10.1002/14651858.CD005182.pub4. PubMed PMID: 20238338.
4. Boulware L et al. An evidence-based review of patient-centered behavioral interventions for hypertension. Am J Prev Med 2001; 21: 221–232. Epub 2001/09/25.
5. Australian Commission on Safety and Quality in Health Care (2010). Patient-Centred Care: Improving quality and safety by focusing care on patients and consumers (Discussion paper). Sydney (NSW Australia): ACSQHC, Commonwealth of Australia.
6. Roumie C et al. Patient centered primary care is associated with patient hypertension medication adherence. J Behav Med 2011; 34: 244–253 Epub 2010/12/17. doi: 10.1007/s10865-010-9304-6. PubMed PMID: 21161578.
7. Stewart M et al. The impact of patient-centered care on outcomes. J Fam Pract 2000; 49: 796–804. Epub 2000/10/14.
8. Lewin S et al. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev 2001; 4: Cd003267 Epub 2001/11/01. doi: 10.1002/14651858.cd003267. PubMed PMID: 11687181.
9. Stewart K et al. (2010). Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease: The pharmacy guild of Australia and the Commonwealth Department of Health and Aging. Available at: http://www.guild.org.au/sites/The_Guild/tab-Pharmacy_Services_and_Programs/Research_and_Development/Fourth%20Agreement/2007%2008-10.page (accessed 29 June 2015).
10. Krass I et al. Diabetes management in an Australian primary care population. J Clin Pharm Ther 2011; 36: 664–672.
11. Armour CL et al. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma 2013; 50: 302–309 Epub 2012/12/29. doi: 10.3109/02770903.2012.754463. PubMed PMID: 23270495.
12. Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother 2009; 43: 1096–1106.
13. Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother 2010; 44: 1922–1929. doi:10.1345/aph.1P373.
14. Castelino RL et al. Use of evidence-based therapy for the prevention of cardiovascular events among older people. Eval Health Prof 2010; 33: 276–301. doi:10.1177/0163278710374854.
15. Hanna T et al. Using scenarios to test the appropriateness of pharmacist prescribing in asthma management. Pharm Pract 2014; 12: 390 Epub 2014/03/20. PubMed PMID: 24644524; PubMed Central PMCID: PMCPmc3955869.
16. Zillich A et al. Evaluation of pharmacist care for hypertension in the Veterans Affairs patient-centered medical home: a retrospective case-control study. Am J Med 2015; 128: 539.e1–e6 doi: 10.1016/j.amjmed.2014.11.027.
17. Mansoor S, Krass I, Aslani P. Multi professional interventions to improve adherence to cardiovascular medications. J Cardiovasc Pharmacol Ther 2013; 18: 19–30.
18. Svarstad B, Bultman D. Remington: The science and practice of pharmacy. The patient: Behavioral determinants. Baltimore: Lippincott Williams & Wilkins, 2000.
19. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006; 18: 59–82.
20. Thomas D. A general inductive approach for analyzing qualitative evaluation data. Am J Eval 2006; 27: 237–246. doi:10.1177/1098214005283748.
21. Australian Government - Department of Human Services. Medicare (About Medicare). Available at: http://wwwhumanservicesgovau/customer/subjects/medicare-services#a3 (accessed 17 June 2015).
22. Worley M. Testing a pharmacist-patient relationship quality model among older persons with diabetes. Res Social Adm Pharm 2006; 2: 1–21 Epub 2006/12/02. doi: 10.1016/j.sapharm.2005.12.006. PubMed PMID: 17138498.
23. Ogden J et al. “I want more time with my doctor”: a quantitative study of time and the consultation. Fam Pract 2004; 21: 479–483 Epub 2004/09/16. doi: 10.1093/fampra/cmh502. PubMed PMID: 15367468.
24. Hughes C, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 2003; 53: 600–606 Epub 2003/11/07. PubMed PMID: 14601335; PubMed Central PMCID: PMCPmc1314673.
25. Bosworth H, Powers B, Oddone E. Patient self-management support: novel strategies in hypertension and heart disease. Cardiol Clin 2010; 28: 655–663 Epub 2010/10/13. doi: 10.1016/j.ccl.2010.07.003. PubMed PMID: 20937448; PubMed Central PMCID: PMCPmc3763915.
26. Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm 2011; 33: 132–140.
27. Morgado M et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm 2011; 68: 241–253 Epub 2011/01/25. doi: 10.2146/ajhp090656. PubMed PMID: 21258029.
28. Ho P, Bryson C, Rumsfeld J. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028–3035. doi:10.1161/circulationaha.108.768986.
29. Hoti K, Hughes J, Sunderland B. An expanded prescribing role for pharmacists - an Australian perspective. Australas Med J 2011; 4: 236–242 Epub 2011/01/01. doi: 10.4066/amj.2011.694. PubMed PMID: 23393515; PubMed Central PMCID: PMCPmc3562903.
30. Health Workforce Australia. Health Professionals Prescribing Pathway project. Available at: https://www.hwa.gov.au/work-programs/workforce-innovation-and-reform/health-professionals-prescribing-pathway-project (accessed 11 November 13).
31. Okamoto M, Nakahiro R. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001; 21: 1337–1344.
32. Tsuyuki R et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION). Circulation 2015; 132: 93–100 Published online before print June 10, 2015, doi: 10.1161/CIRCULATIONAHA.115.015464.
33. Gerard K et al. Valuing the extended role of prescribing pharmacist in general practice: results from a discrete choice experiment. Value Health 2012; 15: 699–707.
34. Hinchliffe A. Pharmacist Independent Prescribing - A Review of the Evidence. Public Health Wales NHS Trust, 2015, Available at: https://www2.nphs.wales.nhs.uk/PharmaceuticalPHTDocs.nsf/($All)/45E9469550B09BB280257DF6004058CE/$File/Pharmacist%20independent%20prescribingv1.1.pdf?OpenElement.
35. West R, Isom M. Management of patients with hypertension: general practice and community pharmacy working together. Br J Gen Pract 2014; 64: 477–478. doi:10.3399/bjgp14X681553.
36. Hadley J. Insurance coverage, medical care use, and short-term health changes following an unintentional injury or the onset of a chronic condition. JAMA 2007; 297: 1073–1084. doi:10.1001/jama.297.10.1073.
37. Bradley F, Ashcroft D, Noyce R. Integration and differentiation: a conceptual model of general practitioner and community pharmacist collaboration. Res Social Adm Pharm 2012; 8: 36–46.
38. Tobari H et al. Physician-pharmacist cooperation program for blood pressure control in patients with hypertension: a randomized-controlled trial. Am J Hypertens 2011; 24: 2–3.